Donna Bergeson is a health care lawyer and former leader of the firm’s Health Care Group. She is a past chair of the firm’s governing body, known as its Partners’ Committee and also chairs the firm’s Investment Committee. Ms. Bergeson focuses her practice on regulatory compliance for academic medical facilities, hospitals, pharmaceutical companies and medical device manufacturers. Donna made partner as a litigator at Alston & Bird and thereafter transitioned to a practice in health care to follow client demand.
Ms. Bergeson has been identified as a “Leading US Health Care Lawyer” by Euromoney, named one of Chambers USA: America's Leading Lawyers for Business, selected by her peers for inclusion in The Best Lawyers in America, and listed in Georgia Super Lawyers magazine. She became certified as a procedural coder in 2001 by the American Academy of Professional Coders to facilitate communication with coding and billing staff on compliance engagements and representations of health care providers defending government investigations.
Ms. Bergeson teaches Health Law as an adjunct faculty member of Emory University School of Law and is a past faculty member of the Atlanta College of Trial Advocacy. She frequently writes and speaks on compliance and life sciences related issues to legal and professional organizations across the country.
Ms. Bergeson has been identified as a “Leading US Health Care Lawyer” by Euromoney, named one of Chambers USA: America's Leading Lawyers for Business, selected by her peers for inclusion in The Best Lawyers in America, and listed in Georgia Super Lawyers magazine. She became certified as a procedural coder in 2001 by the American Academy of Professional Coders to facilitate communication with coding and billing staff on compliance engagements and representations of health care providers defending government investigations.
Ms. Bergeson teaches Health Law as an adjunct faculty member of Emory University School of Law and is a past faculty member of the Atlanta College of Trial Advocacy. She frequently writes and speaks on compliance and life sciences related issues to legal and professional organizations across the country.
Attorney Client Comments